Publication:
Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance

dc.contributor.authorsAgirbasli, Mehmet; Tanrikulu, Azra; Erkus, Emre; Azizy, Munir; Acar Sevim, Busra; Kaya, Zekeriya; Taskin, Abdullah; Aksoy, Nurten; Demirbag, Recep
dc.date.accessioned2022-03-13T12:46:06Z
dc.date.accessioned2026-01-11T19:05:40Z
dc.date.available2022-03-13T12:46:06Z
dc.date.issued2014
dc.description.abstractOxidative stress (OS) is important in the pathogenesis of atherosclerosis. Paraoxonase-1 (PON1) is an enzyme found in the circulation associated with high density lipoprotein (HDL). HDL-associated enzyme PON1 has an important role in the attenuation of atherogenic low density lipoprotein (LDL) oxidation. The aim of this study was to determine PON1 and arylesterase (AREST) enzyme levels in relation to insulin resistance (IR) or obesity among children and adolescents. The study included healthy school children and adolescents. Blood was drawn for the determination of blood glucose, lipid, PON1 and AREST enzyme levels. Overall, we observed a positive correlation between PON1 enzyme activity and high-density lipoprotein cholesterol (HDL-C) levels (r = 0.189, P = 0.014). The correlation appeared to be more significant in boys (r = 0.271, P = 0.009). For subjects with IR and obesity, PON1 enzyme activity did not correlate with HDL-C levels (r=0.038, P=0.790), instead PON1 levels correlated negatively with BMI (r = 0.309 and P=0.026). Multiple linear regression analysis was performed to find the predictors of log PON1 activity. HDL-C level was the strongest predictor of PON1 activity in the lean control group, while BMI appeared to be the strongest predictor in the subjects with obesity or IR. In conclusion, determinants of PON1 enzyme activity are variable in children and adolescents based on IR and obesity. Future studies will shed light on the underlying mechanisms and biomarkers of OS in children and may reveal possible targets for therapeutic intervention.
dc.identifier.doi10.1080/AC.69.6.1000011
dc.identifier.eissn1784-973X
dc.identifier.issn0001-5385
dc.identifier.pubmed25643439
dc.identifier.urihttps://hdl.handle.net/11424/237889
dc.identifier.wosWOS:000346954700011
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS LTD
dc.relation.ispartofACTA CARDIOLOGICA
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectInsulin resistance
dc.subjectoxidative stress
dc.subjectHDL-C
dc.subjectparaoxonase
dc.subjectchildren
dc.subjectLOW-DENSITY-LIPOPROTEIN
dc.subjectBODY-MASS INDEX
dc.subjectCARDIOVASCULAR RISK
dc.subjectMETABOLIC SYNDROME
dc.subjectCHILDHOOD OBESITY
dc.subjectOXIDATIVE STRESS
dc.subjectTURKISH CHILDREN
dc.subjectDYSLIPIDEMIA
dc.subjectSENSITIVITY
dc.subjectOVERWEIGHT
dc.titleSerum paraoxonase-1 activity in children: the effects of obesity and insulin resistance
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage685
oaire.citation.issue6
oaire.citation.startPage679
oaire.citation.titleACTA CARDIOLOGICA
oaire.citation.volume69

Files